[1] Ahmed RM,Hadad GM,El-Gendy AE,Ibrahim A .2018 .Development of HPLC method for determination of sitagliptin in human plasma using fluorescence detector by experimental design approach. Anal. Chem, 8(6) : 813-828.
[2] Al Bratty M,Alhazmi HA,Javed SA,Lalitha KG,Asmari M,Wölker J,El Deeb S J .2017 .Development and validation of LC-MS/MS method for simultaneous determination of metformin and four gliptins in human plasma. Chromatographia., 80(6) : 891-899.
[3] Alquadeib BT .2019 .Development and validation of a new HPLC analytical method for the determination of diclofenac in tablets. Saudi Pharm J., 27(1) : 66-70.
[4] Bahrambeigi S,Yousefi B,Rahimi M,ShafieiIrannejad V M .2019 .Metformin; an old antidiabetic drug with new potentials in bone disorders. Biomed, 109(1) : 1593-1601.
[5] Bashir L,Shoaib MH,Naz S,Yousuf RI,Jabeen S,Israr F,Siddiqui F F .2017 .Development and validation of HPLC method for the determination of cefpodoxime proxetil in human plasma. Pak. J. Pharm Sci., 30(9) : 1603-1607.
[6] Bhende SD,Varanasi MB,Abbulu K,Swetha MD,Shravanthi V,Kumari JK,Shayamala T .2012 .RP-HPLC method for the simultaneous estimation of sitagliptin phosphate and metformin hydrochloride in combined ttablet dosage forms. Orient. J. Chem, 28 : 463.
[7] Habib R,Shoaib MH,Ahmed FR,Siddiqui F,Yousuf RI,Saleem T,Khan MZ .2020 .HPLC-UV method for simultaneous quantitation of artemether and lumefantrine in fixed dose combination orodispersible tablet formulation. Pak. J. Pharm. Sci., 33(4) : 1561-1567.
[8] Hanif S,Irfan N,Danish Z,Hussain N,Ali M,Nasir B,Iqbal J,Saeed H,Ali R .2017 .Computer aided formulation and characterization of propranolol hcl buccal tablet using polymeric blend. Open Conf. Proc. J, 8 : 1-13.
[9] Hanif S,Sarfraz RM,Syed MA,Ali S,Iqbal Z,Shakir R,Iqbal J .2021 .Formulation and evaluation of chitosan-based polymeric biodegradable mucoadhesive buccal delivery for locally acting drugs: In vitro, ex vivo and in vivo volunteers characterization. Lat. Am. J. Pharm., 40(4) : 670-681.
[10] Hussain A,Syed MA,Abbas N,Hanif S,Arshad MS,Bukhari NI,Hussain K,Akhlaq M,Ahmad Z M .2016 .Development of ann optimized mucoadhesive buccal tablet containing flurbiprofen and lidocaine for dental pain. Acta Pharm., 66(2) : 245-256.
[11] Iqbal Q,Bashir S,Jan SU,Malik MZ,Afzal I,Khalid A .2018 .Development of a rapid resolution HPLC method for the quantitative determination of sitagliptin in Human plasma. Pak J. Pharm Sci., 31(3) : 795-799.
[12] Le THH,Phung TH,Le DC .2019 .Development and validation of an HPLC method for simultaneous assay of potassium guaiacolsulfonate and sodium benzoate in pediatric oral powder. J. Anal. Methods Chem, : 6143061.
[13] Maina JW .2018 .Understanding the types and causes of diabetes mellitus. , : .
[14] Malleswararao CS,Suryanarayana MV,Mukkanti K MV .2012 .Simultaneous determination of sitagliptin phosphate monohydrate and metformin hydrochloride in tablets by a validated UPLC method. Scientia pharmaceutica, 80(1) : 139-152.
[15] Mullick P,Mutalik SP,Hegde AR,Pandey A,Jagadish P,Kini SG,Jain S,Mutalik S S .2021 .Simultaneous estimation of apremilast and betamethasone dipropionate in microsponge-based topical formulation using a stability indicating RP-HPLC method: A quality-by-design approach. J. Chromatogr. Sci., : 920-940.
[16] Pena-Pereira F,Wojnowski W,Tobiszewski M .2020 .AGREE analytical GREEnness metric approach and software. Anal. Chem, 92(14) : 10076-10082.
[17] Peraman R,Gowra CS,Reddy YP,Peruru KK .2013 .Stability-indicating RP-HPLC method for simultaneous determination of metformin hydrochloride and sitagliptin phosphate in dosage forms. Chromatographia, 76(17) : 1153-1162.
[18] Razzaq S,Hanif S,Syed MA,Iqbal J,Raza SA,Riaz H,Abid F H .2018 .Development and evaluation of mucoadhesive buccal tablet containing metronidazole for the treatment of periodontitis and gingivitis. Pak J Pharm Sci, 31(5) : 1903-1910.
[19] Razzaq S,Syed MA,Irfan M,Khan I,Sarfraz RM,Shakir R,Ali S,Iqbal Z,Niaz Y,Mujtaba SH .2021 .Optimization of metronidazole SR buccal tablet for gingivitis using genetic algorithm. Pak. J. Pharm. Sci., 34(6) : 2149-2158.
[20] Scott LJ .2017 .Sitagliptin: A review in type 2 diabetes. Drugs, 77 : 209-224.
[21] Sharma M,Beckley N,Nazareth I,Petersen I .2017 .Effectiveness of sitagliptin compared to sulfonylureas for type 2 diabetes mellitus inadequately controlled on metformin: A systematic review and meta-analysis. BMJ open, 7(10) : e017260.
[22] Shyamala M,Mohideen S,Satyanarayana T,Narasimha R,Suresh K,Swetha K K .2011 .Validated RPHPLC for simultaneous estimation of sitagliptin phosphate and metformin hydrochloride in tablet dosage form. Am. J. Pharm. Tech. Res., 1(SUP 2), : 93-101.
[23] Sirigiri N,Subramanian NS,Reddy G,Kumar N G .2018 .Stability indicating method development and validation for simultaneous estimation of sitagliptin phosphate and metformin HCl in tablets by HPLC. Int. J. Pharm. Sci. Res, 9(10) : 4294-302.
[24] Stofella NC,Veiga A,Oliveira LJ,Montin EF,Andreazza IF,Carvalho Filho MA,Bernardi LS,Oliveira PR,Murakami FS .2019 .Solid-state characterization of different crystalline forms of sitagliptin. Materials, 12(15) : 2351.
[25] Swartz ME,Krull IS .2018 .Analytical method development and validation. , : 76-78.
[26] Syed MA,Khan IU,Iqbal MS,Syed HK,Irfan M .2021 .Development of a novel, fast, simple, nonderived RP-HPLC method for simultaneous estimation of benzocaine and tibezonium iodide from mucoadhesive dosage form as well as human saliva and its validation. Lat. Am. J. Pharm., 40(6) : 1281-1287.
[27] van Dalem J,Brouwers MC,Burden AM,Stehouwer CD,Klungel OH,de Vries F,Driessen JH .2021 .Determinants of treatment modification before and after implementation of the updated 2015 NICE guideline on type 2 diabetes: A retrospective cohort study. Diabetes Res. Clin. Pract, 176(1) : 108828.
[28] Zhang F,Tang L,Li J,Yan Z,Li J,Tong N J .2021 .Comparison between pioglitazone/metformin combination therapy and sitagliptin/metformin combination therapy on the efficacy in chinese type 2 diabetic adults insufficiently controlled with metformin: Study protocol of an open-label, multicenter, non-inferiority parallel-group randomized controlled trial. Diabetes Metab Syndr Obes., 14(1) : 1243.